Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H43N5O13.2H2O4S |
Molecular Weight | 781.759 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 16 / 16 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(O)(=O)=O.OS(O)(=O)=O.[H][C@]3(O[C@H]1[C@@H](C[C@H](N)[C@@H](O[C@@]2([H])O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]1O)NC(=O)[C@@H](O)CCN)O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O
InChI
InChIKey=FXKSEJFHKVNEFI-GCZBSULCSA-N
InChI=1S/C22H43N5O13.2H2O4S/c23-2-1-8(29)20(36)27-7-3-6(25)18(39-22-16(34)15(33)13(31)9(4-24)37-22)17(35)19(7)40-21-14(32)11(26)12(30)10(5-28)38-21;2*1-5(2,3)4/h6-19,21-22,28-35H,1-5,23-26H2,(H,27,36);2*(H2,1,2,3,4)/t6-,7+,8-,9+,10+,11-,12+,13+,14+,15-,16+,17-,18+,19-,21+,22+;;/m0../s1
Molecular Formula | H2O4S |
Molecular Weight | 98.078 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C22H43N5O13 |
Molecular Weight | 585.6025 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 16 / 16 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:14:22 UTC 2023
by
admin
on
Fri Dec 15 15:14:22 UTC 2023
|
Record UNII |
N6M33094FD
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
458114
Created by
admin on Fri Dec 15 15:14:22 UTC 2023 , Edited by admin on Fri Dec 15 15:14:22 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/06/387
Created by
admin on Fri Dec 15 15:14:22 UTC 2023 , Edited by admin on Fri Dec 15 15:14:22 UTC 2023
|
||
|
NCI_THESAURUS |
C2363
Created by
admin on Fri Dec 15 15:14:22 UTC 2023 , Edited by admin on Fri Dec 15 15:14:22 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
AMIKACIN SULFATE
Created by
admin on Fri Dec 15 15:14:22 UTC 2023 , Edited by admin on Fri Dec 15 15:14:22 UTC 2023
|
PRIMARY | Description: White or almost white, crystalline powder. Solubility: Freely soluble in water, practically insoluble in acetone R or ethanol (~750 g/l) TS. Category: Antibacterial. Storage: Amikacin sulfate should be kept in a tightly closed container, or if sterile, in a hermetically closed container. Labelling: The label states:- whether the substance is the (1:2) sulfate or the (1:1.8) sulfate form,- the content in terms of Amikacin, calculated with reference to the dried and sulfate-free substance,- where applicable, that the substances is free from bacterial endotoxins,- where applicable, that the substance is sterile. | ||
|
254-648-6
Created by
admin on Fri Dec 15 15:14:22 UTC 2023 , Edited by admin on Fri Dec 15 15:14:22 UTC 2023
|
PRIMARY | |||
|
DBSALT000351
Created by
admin on Fri Dec 15 15:14:22 UTC 2023 , Edited by admin on Fri Dec 15 15:14:22 UTC 2023
|
PRIMARY | |||
|
DTXSID601045247
Created by
admin on Fri Dec 15 15:14:22 UTC 2023 , Edited by admin on Fri Dec 15 15:14:22 UTC 2023
|
PRIMARY | |||
|
C230
Created by
admin on Fri Dec 15 15:14:22 UTC 2023 , Edited by admin on Fri Dec 15 15:14:22 UTC 2023
|
PRIMARY | |||
|
38351
Created by
admin on Fri Dec 15 15:14:22 UTC 2023 , Edited by admin on Fri Dec 15 15:14:22 UTC 2023
|
PRIMARY | |||
|
39831-55-5
Created by
admin on Fri Dec 15 15:14:22 UTC 2023 , Edited by admin on Fri Dec 15 15:14:22 UTC 2023
|
PRIMARY | |||
|
755846
Created by
admin on Fri Dec 15 15:14:22 UTC 2023 , Edited by admin on Fri Dec 15 15:14:22 UTC 2023
|
PRIMARY | |||
|
N6M33094FD
Created by
admin on Fri Dec 15 15:14:22 UTC 2023 , Edited by admin on Fri Dec 15 15:14:22 UTC 2023
|
PRIMARY | |||
|
CHEMBL177
Created by
admin on Fri Dec 15 15:14:22 UTC 2023 , Edited by admin on Fri Dec 15 15:14:22 UTC 2023
|
PRIMARY | |||
|
1019494
Created by
admin on Fri Dec 15 15:14:22 UTC 2023 , Edited by admin on Fri Dec 15 15:14:22 UTC 2023
|
PRIMARY | |||
|
2638
Created by
admin on Fri Dec 15 15:14:22 UTC 2023 , Edited by admin on Fri Dec 15 15:14:22 UTC 2023
|
PRIMARY | |||
|
643
Created by
admin on Fri Dec 15 15:14:22 UTC 2023 , Edited by admin on Fri Dec 15 15:14:22 UTC 2023
|
PRIMARY | RxNorm | ||
|
100000085153
Created by
admin on Fri Dec 15 15:14:22 UTC 2023 , Edited by admin on Fri Dec 15 15:14:22 UTC 2023
|
PRIMARY | |||
|
m1670
Created by
admin on Fri Dec 15 15:14:22 UTC 2023 , Edited by admin on Fri Dec 15 15:14:22 UTC 2023
|
PRIMARY | Merck Index | ||
|
SUB00444MIG
Created by
admin on Fri Dec 15 15:14:22 UTC 2023 , Edited by admin on Fri Dec 15 15:14:22 UTC 2023
|
PRIMARY | |||
|
N6M33094FD
Created by
admin on Fri Dec 15 15:14:22 UTC 2023 , Edited by admin on Fri Dec 15 15:14:22 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
Amikacin sulfate is a semi-synthetic product derived from a fermentation product, kanamycin A. Amikacin sulfate (1:2) contains not less than 96.5% and not more than 102.0% of amikacin sulfate (C22H43N5O13,2H2SO4), calculated with reference to the dried substance. Amikacin sulfate (1:1.8) contains not less than 96.5% and not more than 102.0% of amikacin sulfate (C22H43N5O13,1.8H2SO4), calculated with reference to the dried substance.
|
||
|
IMPURITY -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||